metoprine has been researched along with Melanoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alberto, P; Brugarolas, A; Cavalli, F; Hansen, HH; Klepp, O; Renard, J | 1 |
| Hill, BT; Price, LA | 1 |
1 review(s) available for metoprine and Melanoma
| Article | Year |
|---|---|
DDMP (2,4-diamino-5-(3',4'-dichlorophenyl)-methylpyrimidine).
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Carcinoma, Squamous Cell; Diarrhea; Drug Administration Schedule; Drug Evaluation; Head and Neck Neoplasms; Humans; Lethal Dose 50; Leukopenia; Lung Neoplasms; Melanoma; Mice; Neoplasms, Experimental; Pyrimethamine; Rats; Seizures | 1980 |
1 other study(ies) available for metoprine and Melanoma
| Article | Year |
|---|---|
Phase II study of diamino-dichlorophenyl-methylpyrimidine (DDMP) with folinic acid (CF) protection and rescue.
Topics: Adenocarcinoma; Carcinoma, Squamous Cell; Child; Drug Evaluation; Drug Therapy, Combination; Folic Acid Antagonists; Head and Neck Neoplasms; Humans; Leucovorin; Leukocyte Count; Melanoma; Neoplasms; Platelet Count; Pyrimethamine; Sarcoma | 1980 |